Infusing more resources in educating and spreading awareness to destigmatise cannabis and spread awareness on its myriad wellness benefits
Delhi-based cannabis wellness startup Awshad has announced the launch of their new prescription product – a cannabis medicinal capsule line branded as ‘Calmasule’. The objective behind this roll-out of the new product line of Awshad is to help people experience the healing qualities of cannabis in the form of a capsule in order to enable them to alleviate pain, insomnia, stress and various other lifestyle ailments through an all-natural solution and thus aid their overall well-being.
With this new line of products, Awshad intends to expand its target audience and customer base and thereby increase sales and revenue in order to consolidate market leadership.
Awshad has been working with leading cannabis manufacturing and formulation teams in India in a bid to come out with these superlative, pure cannabis extract capsules that have been proven to have very high efficacy and showed extremely promising results amongst the focus groups. Only if and when they have a prescription, the customers would be able to buy Awshad’s newly-launched capsule products directly from the Awshad website or via aggregator marketplaces like CBD Store, It’s Hemp and others.
Awshad’s new range of capsules have been made available under two variants: Calmasule and Calmasule Plus. With 10mg CBD (Cannabidiol) and 5mg THC or Tetrahydrocannabinol (2:1 CBD: THC ratio), Calmasule helps patients combat anxiety, stress, insomnia and mild pain issues. On the other hand, Calmsule+ is a much stronger product variant with 15mg CBD and 15mg THC (1:1 CBD: THC ratio), thus especially recommended for those facing chronic and more serious ailments like chronic pains, chronic insomnia, cancer, Parkinson’s, epilepsy, arthritis, etc.
Notably, all of Awshad’s products are intensively lab-tested and certified by the Ministry of AYUSH, Government of India.